POPULARITY
10 episodes with artios
3 episodes with artios
3 episodes with artios
6 episodes with artios
7 episodes with artios
2 episodes with artios
2 episodes with artios
Gesprek met Marianne Buitink auteur van het boekje "Leven met verlies, rouwen terwijl er niemand is overleden". Een uitgave van uitgeverij Groen (Artios-reeks), onderdeel van de Royal Jongbloed Mediagroep (https://www.jongbloedmedia.nl/product/artios-reeks-leven-met-verlies/) Van hun site: Rouw kan ook aanwezig zijn bij afnemende gezondheid, verlies van werk, een onvervulde kinderwens, uiteengespatte toekomstdromen, zogenoemd ‘levend verlies'. In Leven met verlies komt deze rouw op een persoonlijke, nuchtere manier aan de orde. Vanuit een bijbelse en geestelijke insteek worden handvatten aangeboden om met dit verdriet om te gaan. • Artios-uitgave over rouw bij andere situaties dan overlijden. • Een invoelend en bemoedigend boek voor ervaringsdeskundigen, en ook voor predikanten, pastoraal werkers en ambtsdragers een must-read.
We review most of the Oscar Nominated Shorts, I'm Still Here & The Girl with the Needle, update some of the experts predictions heading into BAFTA, react to VES, SCL & Artios + we recap all of the Super Bowl Movie Trailers and more! Updated Predictions from Experts, Our Feel + M1's Ted Talk on Oscars History - 1:29 OSCAR NOMINATED SHORTS REVIEWED: Live Action Betting Odds + Anuja on Netflix - 8:30 I'm Not A Robot + Radiohead covers - 12:42 A Lien + Horror Realism - 14:31 Doc Short Betting Odds + The Only Girl in the Orchestra on Netflix - 15:53 I Am Ready, Warden on Paramount Plus - 19:34 Instruments of a Beating Heart + Pandemic Kids - 23:41 Incident + A Lawyer's Perspective - 28:37 Animated Short Betting Odds + Wander To Wonder - 31:11 Beautiful Men + More Claymation Penis - 34:12 I'm Still Here - 35:22 The Girl With The Needle - 38:55 VES: Visual Effects Society Winners - 42:19 SCL: Society of Composers & Lyricists Winners - 44:13 Artios Awards from the Casting Society - 46:37 Super Bowl Trailer Reviews include Novacaine, Thunderbolts*, Lilo & Stitch, Mission: Impossible - The Final Reckoning, How To Train Your Dragon, F1, Megan 2.0, Smurfs, The Fantastic Four: First Steps - 48:26 More What We're Watching: M1's Twin Peaks: The Return rewatch, Tom Green's New Doc + Stand-Up Special, You're Cordially Invited, Goodrich, + The Before Trilogy & Anora rewatches - 59:27 OUTRO: What'd you think of the Oscar Nominated Shorts? Or what have you caught up with in terms of the nominees that you liked or disliked? Let us know. https://linktr.ee/mikemikeandoscar This is the calm before the Oscars storm as we enjoy one final Oscar Race Checkpoint before BAFTA.
Today on What's My Frame I'm joined by Casting Director, Susan Shopmaker. For over two decades, Susan has been a recognized name in the world of independent film for her work as a casting director on numerous award-winning films. From large ensembles to small-scale intimate dramas. Susan's ability to perfectly match an actor and role has been showcased in Martha Marcy May Marlene, Beach Rats, The Holdovers, Life Itself & The Iron Claw. In 2018 Susan won the Artios Award for Eliza Hittman's Beach Rats and previously won an Artios for Sean Durkin's acclaimed Sundance drama Martha Marcy May Marlene. Susan Shopmaker CastingFollow Susan on IGSusan's additional credits include: Paul Schrader's First Reformed, The Card Counter and worked on his latest, The Master Gardener. Susan also cast John Cameron Mitchell's cult classic Hedwig and the Angry Inch, John Slattery's God's Pocket & Maggie Moore(s), Michel Franco's Chronic (Cannes 2015 Award Winner & 2017 Spirit Award Nominee), Franco's Sundown (2021), and The Nest for Sean Durkin.What's My Frame, hosted by Laura Linda BradleyJoin the WMF creative community now!Instagram: @whatsmyframeIMDbWhat's My Frame? official siteWhat's My Frame? merch
A Canadian man is arrested in relation to the Snowflake hacks from earlier this year - after a cybersecurity researcher managed to track his identity, and a cryptocurrency-trading Instagram influencer is in trouble with the law.All this and more is discussed in the latest edition of the "Smashing Security" podcast by cybersecurity veterans Graham Cluley and Carole Theriault.Warning: This podcast may contain nuts, adult themes, and rude language.Episode links:Accused Kitchener hacker unmasked after threatening woman online - The Waterloo Region Record.Canadian Man Arrested in Snowflake Data Extortions - Krebs on Security.Who wants to be next? - Bluesky post by Allison Nixon.Crypto Trader Kills His Mum For £500k After Going Into Debt To Maintain 'Perfect Lifestyle' - IB Times. Autopsy reveals injuries on body of Colleen Rebelo's body after alleged murder - Australia News.Influencer Marketing Statistics 2024 - Artios.BLACKkKLANSMAN trailer - YouTube.A Soft Murmur.Smashing Security merchandise (t-shirts, mugs, stickers and stuff)Sponsored by:1Password Extended Access Management – Secure every sign-in for every app on every device.BigID - Start protecting your sensitive data wherever it lives with BigID. Get a free demo to how your organization can reduce data risk and accelerate the adoption of generative AI.ThreatLocker - the Zero Trust endpoint protection platform that provides enterprise-level cybersecurity to organizations globally. Start your 30-day free trial today!SUPPORT THE SHOW:Tell your friends and colleagues about “Smashing Security”, and leave us a review on Apple Podcasts or Podchaser.Become a supporter via Patreon or Apple Podcasts for ad-free episodes and our early-release feed!FOLLOW US:Follow us on
Today on What's My Frame I'm joined by Jeremy O'Keefe. Jeremy is an award-winning director, writer, producer, casting director and educator. His second feature, Somewhere Slow won Best Narrative Feature at the Brooklyn Film Festival, was released theatrically by Screen Media. Currently he is producing and casting the feature films including Eyes in the Trees (Anthony Hopkins, Jonathan Rhys Meyers), The Wolf and the Lamb (Angus Macfadyen). Jeremy spent over nine years in TV comedy with Greenstein / Daniel Casting and Sherie Hernandez Casting in Los Angeles, earning him both Artios and Heller nominations. He's worked with every major network and streaming platform. Hightlights include Mindy Kaling's ground-breaking Netflix series, Never Have I Ever, the Carol Burnett / Amy Poehler pilot Household Name for ABC, the first 2 seasons of TVLand's Teachers and the final 2 seasons of Key and Peele (both with Sherie Hernandez). In addition to casting, as an educator, Jeremy has been on the faculty at AMDA and a guest for Wallace State, Webster University and American Academy of Dramatic Art. He teaches mindfulness-based audition technique across the country. He is committed discovering and fostering original, authentic talent and maximizing the positive impact TV, film and theatre can have on its audiences, and the world. Follow Jeremy on IG @jeremyokeefe --- What's My Frame, hosted by Laura Linda Bradley Join the WMF creative community now! Instagram: @whatsmyframe TikTok: @whatsmyframe IMDb What's My Frame? official site Join our monthly newsletter! What's My Frame? merch --- Support this podcast: https://podcasters.spotify.com/pod/show/whats-my-frame/support
Today on What's My Frame I'm joined by Emmy nominated and Artios award winning casting director, producer, writer/director, and educator Erica Arvold. Erica has contributed to the making of over 150 films, 90 television shows, and countless multimedia & commercial projects. She recently won an Artios Award for Dopesick and has been nominated five additional times. Casting credits include Burden of Proof, Black Adam, Tell Me Lies, Red Notice, The Game, The Good Lord Bird and Dopesick to name a select few. As an advocate for artists, she has spoken, moderated panels, and mentored filmmakers at Austin Film Festival Screenwriters Conference, Independent Television Festival, Richmond International Film Festival, and Virginia Film Festival, among others. In 2010, Erica founded arvold.education to cultivate artistic growth in actors and filmmakers, which quickly expanded into Arvold Warner Studio. Her collaboration with teaching artist/actor/director Richard Warner focuses not only on actor training but also how artistry can improve life. Learn more about Arvold Warner Studios! --- What's My Frame, hosted by Laura Linda Bradley Join the WMF creative community now! Instagram: @whatsmyframe TikTok: @whatsmyframe IMDb What's My Frame? official site Join our monthly newsletter! What's My Frame? merch --- Support this podcast: https://podcasters.spotify.com/pod/show/whats-my-frame/support
Dr. Allison Zibelli and Dr. Erika Hamilton discuss the results of the DESTINY-Breast06 trial in HR+, HER2-low and HER2-ultralow metastatic breast cancer and the A-BRAVE trial in early triple-negative breast cancer, the results of which were both presented at the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Allison Zibelli: Hello, I'm Dr. Allison Zibelli, your guest host of the ASCO Daily News Podcast. I'm an associate professor of medicine and breast medical oncologist at the Sidney Kimmel Cancer Center of Jefferson Health in Philadelphia. My guest today is Dr. Erika Hamilton, a medical oncologist and director of breast cancer research at the Sarah Cannon Research Institute. We'll be discussing the DESTINY-Breast06 trial, which showed a progression-free advantage with the antibody-drug conjugate trastuzumab deruxtecan (T-DXd) compared to chemotherapy in hormone receptor-positive HER2-low or HER2-ultralow metastatic breast cancer. We'll address the implications of this study for the community, including the importance of expanding pathology assessments to include all established subgroups with HER2 expression, and the promise of expanding eligibility for antibody-drug conjugates. We'll also highlight advances in triple-negative breast cancer, focusing on the A-BRAVE trial, the first study reporting data on an immune checkpoint inhibitor avelumab in patients with triple-negative breast cancer with invasive residual disease after neoadjuvant chemotherapy. Our full disclosures are available in the transcript of this episode. Erika, it's great to have you on the podcast today. Dr. Erika Hamilton: Thanks so much, Allison. Happy to join. Dr. Allison Zibelli: Antibody-drug conjugates are rapidly changing the treatment landscape in breast cancer. The data from the DESTINY-Breast06 trial suggests that trastuzumab deruxtecan may become a preferred first-line treatment option for most patients with HER2-low or HER2-ultralow metastatic breast cancer after progression on endocrine therapy. First, could you remind our listeners, what's the definition of HER2-ultralow and what were the findings of this trial? Dr. Erika Hamilton: Yeah, those are fantastic questions. Ultralow really has never been talked about before. Ultralow is part of a subset of the IHC zeros. So it's those patients that have HER2-tumor staining that's less than 10% and incomplete but isn't absolutely zero. It's even below that +1 or +2 IHC that we have classified as HER2-low. Now, I think what's important to remember about D-B06, if you recall, D-B04 (DESTINY-Breast04) was our trial looking at HER2-low, is that D-B06 now included HER2-low as well as this HER2-ultralow category that you asked about. And it also moved trastuzumab deruxtecan up into the frontline. If you recall, D-B04 was after 1 line of cytotoxic therapy. So now this is really after exhausting endocrine therapy before patients have received other chemotherapy. And what we saw was an improvement in progression-free survival that was pretty significant: 13.2 months versus 8.1 months, it was a hazard ratio of 0.62. And you can ask yourself, “well, was it mainly those HER2-low patients that kind of drove that benefit? What about the ultralow category?” And when we look at ultralow, it was no different: 13.2 months versus 8.3 months, hazard ratio, again, highly significant. So I think it's really encouraging data and gives us some information about using this drug earlier for our patients with hormone receptor-positive but HER2-negative disease. Dr. Allison Zibelli: I thought this study was really interesting because it's a patient population that I find very difficult to treat, the hormone receptor-positive metastatic patient that's not responding to endocrine therapy anymore. But it's important to mention that T-DXd resulted in more serious toxicities compared to traditional chemotherapy in this study. So how do you choose which patients to offer this to? Dr. Erika Hamilton: Yeah, those are both great points. So you're right, this is after endocrine therapy. And in fact, about 85% of these patients had received at least 2 prior lines of endocrine therapy. So I have some people kind of asking, “Well, if endocrine therapy really isn't benefiting everyone in the second-line setting post-CDK, should we just move to the ADCs?” And, no, probably we should really make sure that we're exhausting endocrine therapies for those patients that are going to benefit. And once we determine somebody has endocrine-resistant disease, that's when we would think about switching. In terms of the side effects, I think you're right. It's mainly ILD that's probably the more serious side effect that we worry about a little bit with trastuzumab deruxtecan. The good news is, through multiple trials, we've gotten a little bit better at managing this. We've pretty much all but eliminated any fatal cases of ILD, definitely less than 1% now. ILD rates, depending on what study you look for, kind of ranges in that 10% to 15% range. Any grade ILD on D-B06 was 11.3%. So really kind of making sure that we look for ILD at scans, making sure that patients are educated to tell us about any new pulmonary symptoms: cough, exertional dyspnea, shortness of breath at rest, etc. But I think the most common side effects that we really deal with on a daily basis with trastuzumab deruxtecan, luckily, is nausea, which we've gotten better at managing with the 2- or 3-drug antiemetic regimen, and probably a little bit of fatigue as well. Dr. Allison Zibelli: Thank you. So, I think for most people in the community, the sticking point here will be expanding pathology assessments to include all of the subgroups, including the ultralow. Most patients in the community are not testing for HER2-low and HER2-ultralow now. Dr. Erika Hamilton: Historically, we kind of all did HER2 IHC, right? And then as FISH became available, there were a lot of institutions that moved to FISH and maybe didn't have IHC anymore. And now, at least in my institution, we do both. But I think it's a very important point that you made that IHC was really designed to pick out those patients that have HER2-high, the 3 pluses or the FISH amplified cases. It was not to tell the difference between a 1+ or a 2+ or a 0 that's not quite a 0 and a 1+. So I think you're right. I think this is tough. I probably have a little bit more of an interesting take on this than some people will. But data from ASCO, not this year but in 2023, there was actually a pretty eloquent study presented where they looked at serial biopsies in patients, and essentially, if you got up to 4 or 5 biopsies, you were guaranteed to have a HER2-low result. Now, this didn't even include ultralow, which is even easier. If we know we include ultralow, we're really talking about probably 85% to 90% of our patients now that have some HER2 expression. But if we biopsy enough, we're guaranteed to get a HER2 low. And so I think the question really is, if we know IHC wasn't really designed to pick out these ultralows, and we know kind of greater than 90% of patients are going to have some expression, did we kind of develop this drug a little bit backwards? Because we thought we understood HER2, and the reality is this drug is a little bit more like a sacituzumab govitecan, where we don't test for the TROP2. Should we really be kind of serial biopsying these patients or should maybe most patients have access to at least trying this drug? Dr. Allison Zibelli: So I don't think that most of my patients will really be happy to sign up for serial biopsies. Dr. Erika Hamilton: Agreed. Dr. Allison Zibelli: Do we have any emerging technologies for detecting low levels of HER2? You talked about how the IHC test isn't really designed to detect low levels of HER2. Do you think newer detection techniques such as immunofluorescence will make a difference, or will we have liquid biopsy testing for this? Dr. Erika Hamilton: Yeah, I think liquid biopsy may be a little bit hard, just because some of those circulating tumor cells are more of a mesenchymal-type phenotype and don't necessarily express all of the same receptors. Normally, if they're cytokeratin-positive, they do, but certainly there is a lot out there looking at more sensitive measures. You mentioned immunofluorescence, there are some even more quantitative measures looking at lower levels of HER2. I definitely think there will be. I guess, ultimately, with even the IHC zeros that are the less than 10% incomplete staining, having a PFS that was absolutely no different than the HER2 low, I guess the question is, how low can we really go? We know that even the IHC zeros doesn't mean that there's no HER2 expression on the cell surface. It just means that maybe there's a couple of thousand as opposed to 10,000 or 100,000 copies of HER2. And so it really appears that perhaps this drug really is wedded to having a lot of HER2 expression. So ultimately, I wonder how much we're going to have to use those tests, especially with what we know about tumor heterogeneity. We know that if we biopsy 1 lesion in the liver, biopsy a lymph node, or even another lesion in the liver, that the HER2 results can have some heterogeneity. And so ultimately, my guess is that most people have some HER2 expression on their breast cancer cells. Dr. Allison Zibelli: So maybe we're going to be using this for everybody in the future. Dr. Erika Hamilton: It certainly seems like we keep peeling back the onion and including more and more patients into the category that are eligible to receive this. I agree. Dr. Allison Zibelli: Let's move on to triple-negative breast cancer, namely the A-BRAVE trial. This was an interesting trial for patients that did not get neoadjuvant immunotherapy and testing 2 groups. The first group was those with residual disease after neoadjuvant conventional chemotherapy. The second group was people with high-risk disease identified upfront that had upfront surgery. The study found that adjuvant avelumab did not improve disease-free survival versus observation, which was the study's primary endpoint. But interestingly, there was a significant improvement in 3-year overall survival and distant disease-free survival. Can you give us your thoughts on that? Dr. Erika Hamilton: Yeah, I think this study was really interesting. Right now, the standard for our patients with larger or node-positive triple-negative cancers is KEYNOTE-522. It's a pretty tough regimen. It's kind of 2 sequential uses of 2 chemotherapies, so 4 chemotherapy agents total with pembrolizumab. But you're right, this study looked at those that had residual disease after neoadjuvant that didn't include immunotherapy, or those patients that didn't get neoadjuvant therapy, went to surgery, and then were receiving chemotherapy on the back end. I'm going to give you the numbers, because you're right. The 3-year disease-free survival rates were not statistically significant. It was 68.3% among those that had avelumab, 63.2% with those that had observation only. So the difference was 5.1% in favor of avelumab, but it wasn't statistically significant. A p value of 0.1, essentially. But when we looked at the 3-year overall survival rates, we saw the same pattern, those patients with the avelumab doing better, but it was 84.8% overall survival and not, unfortunately, dying, versus 76.3%. So the magnitude of benefit there was 8.5%, so about 3% higher than we saw for disease-free survival, and this was statistically significant. So is this going to change practice for most patients? I probably don't think so. I think for our patients that have larger tumors that's recognized upfront or have node positivity, we're probably going to want to use neoadjuvant chemo. Being able to get a PCR is very prognostic for our patients and enables us to offer things on the back end, such as PARP inhibitors or further chemotherapy of a different type of chemotherapy. But for our patients that go to surgery and maybe the extent of their disease just isn't recognized initially, this could be an option. Dr. Allison Zibelli: I agree. I think this will be a really useful regimen for patients where we get the surprise lymph node that we weren't expecting, or somebody who comes to us, maybe without seeing the medical oncologist, who got upfront surgery. So I thought this was really interesting. What kind of translational studies do you think we're going to do to try and understand which patients would benefit from avelumab? Dr. Erika Hamilton: Yeah, I think that's a great question, and honestly, it's a question that we haven't really answered in the neoadjuvant setting either. Immunotherapy in breast cancer is just a little bit different than it is in some other diseases. We have a benefit for those patients that are PD-L1 positive in the first line. We really haven't seen benefit for metastatic outside of first line. And then in neoadjuvant, it was among all comers. We don't have to test for PD-L1. And now we have this avelumab data from A-BRAVE. I think the question is, is there's probably a subset of patients that are really getting benefit and a subset that aren't. And I don't know that PD-L1 testing is the right test. We know a lot of people are looking at TILs, so kind of lymphocytes that are infiltrating the tumor, a variety of other kind of immunologic markers. But my guess is that eventually we're going to get smart enough to tease out who actually needs the immunotherapy versus who isn't going to benefit. But we're not quite there yet. Dr. Allison Zibelli: Thank you, Erika, for sharing your valuable insights with us on the ASCO Daily News Podcast today. Dr. Erika Hamilton: Thanks so much for having me. Dr. Allison Zibelli: And thank you to our listeners for joining us. You'll find the links to all the abstracts discussed today in the transcript of this episode. Finally, if you like this podcast and you value our insights, please take a moment to rate, review, and subscribe wherever you get your podcasts. It really helps other people to find us. So thank you very much for listening today. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. Allison Zibelli Dr. Erika Hamilton @ErikaHamilton9 Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Allison Zibelli: None Disclosed Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics
We loved shining a light on the absolutely wonder Erica Bream. She is a gem in the casting community, who genuinely adores actors and the opportunity to collaborate with them. Whether it's in a formal audition setting, coaching or teaching audition technique...anyone with eyes can see her love of actors. ERICA S. BREAM has worked a Casting Director on projects across all mediums, including on titles such as ECHOES (Netflix), DOLLY PARTON'S MOUNTAIN MAGIC CHRISTMAS (NBC), THE WINCHESTERS (CW), ALTERED CARBON (Netflix), 11:22.63 (Hulu), PANHANDLE (Spectrum) and many others. Notably, Bream has co-cast sixteen seasons of the prestigious Young Playwrights Festival for The Blank Theatre Company. Over the years, Bream's work in theatre, short film and television casting has garnered her nine Artios nominations and a win in the Los Angeles Theatre category. Resources: Free Tickets to Young Playrights Festival Erica Bream - Casting & Consulting Erica Bream's Instagram Erica Bream's IMDB ──────────────────────────── Stay Tuned with Tipsy Casting on IG Watch the Tipsy Casting YouTube Channel Follow Jessica & Follow Jenn Learn More About Jess & Jenn's Casting --- Send in a voice message: https://podcasters.spotify.com/pod/show/tipsycastingpodcast/message
Amanda Lenker Doyle, CSA is a self proclaimed treasure hunter. Obsessed with all things shimmery and bright, she has dedicated her life to the hunt for gems, jewels…and actors. After nearly two decades in film and television casting, Amanda has earned numerous accolades for her work. In 2018, she took home an Artios trophy for her work in Los Angeles theater production of “WAITING FOR GODOT” and in 2022, her short film "PLEASE HOLD" received an Academy Award nomination, showcasing her expertise in identifying and nurturing talent. Also notable among her credits is the critically acclaimed film "R#J," which made waves at Sundance and SXSW in 2021 as well as the hit film "WE BROKE UP," currently streaming on Hulu. She has contributed her casting expertise to many popular TV series such as "BLACK-ISH" and "THE MUPPETS" for ABC, "ZAC & MIA" for Netflix, and "WAYNE," now available on Amazon Prime. Beyond her role as a Casting Director, Amanda has also made a significant impact as a Producer. With a passion for bringing stories to life, she excels in overseeing all aspects of a production, from concept development through post. Her strong leadership skills and ability to assemble exceptional creative teams have resulted in the successful realization of numerous projects. As a Producer, Amanda understands the importance of creating an environment where talent can thrive. A connector-of-artists in all aspects of her creative life, Amanda believes that every actor should have an opportunity to shine — and she can't wait to see what beautiful gems she digs up.
This month for our series: Introduction to a Modern Class of Casting Visionaries we welcome our good friend Jenny Jue! Jenny has been nominated for two Casting Artios awards for work on independent films with Gregg Araki and Werner Herzog. She won the Artios award in 2009 for her work with Quentin Tarantino on INGLOURIOUS BASTERDS. Other projects include two feature films for Director Bong Joon Ho - SNOWPIERCER and OKJA, and the Netflix series THE BROTHERS SUN. In this episode: We start this week by clearing up a rumor that has come to our attention along with revisiting the reasons as to why we started Tipsy Casting Drinks of the Week! Jenny's origin story of how she got started in her casting career What her experience was like going out on her own after working with Johanna Ray Jenny shares her views on the current state of casting and her concerns for future casting directors, associates and assistants What is her favorite thing about her job and how she loves collaboration Diving into the casting process of her Netflix series "The Brothers Son" Access to Casting jobs and the struggle casting faces especially with Studio Casting Executives not willing to approve the new generation Talent crushes and how she is breaking the mold of bringing new faces onto the scene No win situations for CDs and how Jenny handles them Resources: Jenny's Instagram Jenny's IMDB Jenny's Website ──────────────────────────── Stay Tuned with Tipsy Casting on IG Watch the Tipsy Casting YouTube Channel Follow Jessica & Follow Jenn Learn More About Jess & Jenn's Casting Journeys Get Casting Life Away Merch here! --- Send in a voice message: https://podcasters.spotify.com/pod/show/tipsycastingpodcast/message
In this insightful interview, I sit down with Andreas Voniatis, the founder of Artios and author of the book "Data-Driven SEO with Python." Andreas, an SEO veteran with over 20 years of experience, shares his journey in the world of search engine optimization and discusses the importance of data-driven approaches in modern SEO. He provides real-life examples of how he has applied data science and machine learning to tackle various SEO challenges, from optimizing information architecture to recovering from algorithm updates. Andreas also shares his thoughts on the impact of AI on the SEO industry and offers valuable advice for those just starting in the field. Tune in to learn more about data-driven SEO and how it can help you make better decisions and achieve better results. Don't forget to subscribe to my channel, SEO Sly, to learn SEO for free with me! Follow Andreas Voniatis Website: https://artios.io/book/ LinkedIn: https://www.linkedin.com/in/andreas-artios/ X/Twitter: https://twitter.com/andreasvoniatis Follow SEO Consultant Olga Zarr or hire Olga to help you with SEO Follow Olga Zarr X/Twitter Follow Olga Zarr on LinkedIn The best SEO newsletter The best SEO podcast SEO consultant Olga Zarr
Jenn and Jess recap this year's CSA Artios Awards. Those are the casting awards that the Casting Society holds every year (for those who may not know). While Jenn attended the London ceremony, Jess attended and was nominated (twice!) in LA. Always a fun time and lastly we make our Oscar predictions even though we know the Oscars will air by the time this episode drops! Don't forget to tune into Netflix to watch YOUR LUCKY DAY that our very own Jessica Sherman cast! Comment or send us a DM of what you thought after you watch. See you next week as we do a full Oscar wrap up! Cheers! ──────────────────────────── Stay Tuned with Tipsy Casting on IG Watch the Tipsy Casting YouTube Channel Follow Jessica & Follow Jenn Learn More About Jess & Jenn's Casting --- Send in a voice message: https://podcasters.spotify.com/pod/show/tipsycastingpodcast/message
The Academy of Motion Picture Arts and Sciences announced they're adding the Best Casting category to the Academy Awards in 2026 (awarding movies made in 2025). If you're scratching your head as to why casting should get its own award, you're not alone. I thought this award would just comprise of the movie with the most A-listers, "might equals right" scenario. Enter Kate Geller, a New York-based casting director with nearly 100 projects under her belt, from assisting on the first two JOHN WICK movies and THE MAZE RUNNER to working as casting director for MOLLI AND MAX IN THE FUTURE (covered on this podcast!) SHIVA BABY and MARCEL THE SHELL WITH SHOES ON. She actually won ARTIOS awards for the latter two movies, so who better to weigh in on the topic, along with teaching me perspective on how much work goes into casting - and ultimately, kick-starting - a movie? --- Follow Kate on Instagram: @kategellercasting Follow The Movies on Twitter: @themovies_pod --- Music: Marlowe - "Cold Open" Jeff Rosenstock - "Rainbow" --- Send in a voice message: https://podcasters.spotify.com/pod/show/themoviespodcast/message
This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, chief financial officer at OncoC4, a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. This includes first-in-class immunotherapy products such as novel antibodies and CAR T-cell treatments targeting CTLA-4.OncoC4 is a spinout of OncoImmune, which was acquired by Merck in December 2020. OncoImmune was founded in 2000 based on the scientific discoveries of the company's founders who moved their lead product from a basic concept into clinical trials for multiple indications.Dr. Liu is recognized internationally for his research on immune recognition of cancer and activation of lymphocytes. He has received several academic and research awards including the Snyder Award for Cancer Research in 2015, and was elected to the rank of fellow at the American Association for Advancement of Science (AAAS) in 2004 for his pioneering contribution to innate immunity, T cell costimulation and cancer immunology. Prior to serving full-time as OncoC4's CEO, Dr. Liu was a faculty member at multiple academic institutions, including New York University and the Ohio State University.Abid Ansari is a finance executive with a more 20-year track record in the life sciences industry encompassing corporate finance, fundraising, business development and investor relations experiences for public and private life science companies. Previously, he served as CFO of Artios, a UK-based DNA damage response company where he led the company's $153 million Series C fundraising. Earlier in his career, Abid held positions at GlaxoSmithKline (GSK) in deal finance and portfolio management. Tune into the episode to hear more about the development of new, cutting-edge cancer treatments, including current challenges in oncology and immunotherapies. Also hear about OncoC4's collaborations including a co-development commercialization partnership with BioNTech on its lead product and a collaboration with Merck. For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Today on What's My Frame I'm joined by casting director Erica A. Hart. Erica was born and raised in Washington, DC. She graduated from NYU's Tisch where she studied film and television. We dive into her time there, her first experiences casting and the lasting community she found amongst her fellow students. Erica has been casting for over a decade and as you'll hear in our conversation she loves her work and loves the opportunity to create with fellow artists. She started off in the studio/network space at ABC Primetime Casting and then moved to independent casting. Erica shares stories from casting THAT DAMN MICHAEL CHE (MAX), BUST DOWN (PEACOCK); her Broadway premier CHICKEN and BISCUITS and more. Erica is an Artios award winner, a CSA Board Member, and all around incredible casting director championing for actors. We had so much fun recording this one! Now let's get to the conversation Stream Erica's film, THE SURROGATE on Prime Follow Erica on Instagram ---- Hosted by Laura Linda Bradley Join the WMF creative community now! Instagram: @whatsmyframe TikTok: @whatsmyframe IMDb What's My Frame? official site Join our monthly newsletter! What's My Frame? merch Proceeds will be donated to the SAG-AFTRA Foundation to support actors affected by the strikes. --- Support this podcast: https://podcasters.spotify.com/pod/show/whats-my-frame/support
Michael Donovan is the recipient of 9 Artios awards. He has cast more than 1,000 shows produced at such venues as the Ahmanson Theatre, the Mark Taper Forum, the Hollywood Bowl, Pasadena Playhouse, the Kirk Douglas Theatre, Walt Disney Concert Hall, Laguna Playhouse, and International City Theatre. He has cast national tours, numerous films, TV series and commercials. Michael is the President of the Board for the Foundation for New American Musicals, teaches at both Pepperdine and USC, and serves on the board for Camp Bravo. ▬▬▬▬▬▬▬▬ MICHAEL DONOVAN ⌲ IMDb: https://www.imdb.com/name/nm0233036/ ⌲ IG: https://www.instagram.com/michaeldonovancasting/?hl=en ⌲ Website: https://michaeldonovancasting.com/ ▬▬▬▬▬▬▬▬ The Moving Spotlight Podcast ⌲ iTunes: https://podcasts.apple.com/us/podcast/the-moving-spotlight/id1597207264 ⌲ Spotify: https://open.spotify.com/show/7cjqYAWSFXz2hgCHiAjy27 ⌲ Patreon: https://www.patreon.com/themovingspotlight ⌲ ALL: https://linktr.ee/themovingspotlight ▬▬▬▬▬▬▬▬ #Musicals #LosAngelesTheatre #NYCTheatre #Broadway #MarkTaperForum #PasadenaPlayhouse #AhmansonTheatre #TheatreCasting #TheatreCastingDirector #SelfTapes #RichieFerris #MichaelDonovanCasting #Emmys #TVTime #iTunes #Actor #ActorsLife #Believe #Success #Inspiration #Netflix #Hulu #Amazon #HBO #AppleTV #Showtime #Acting #Artist #Theatre #Film #YourBestBadActing #Content #CorbinCoyle #JohnRuby #RealFIREacting #TMS_Pod --- Support this podcast: https://podcasters.spotify.com/pod/show/the-moving-spotlight/support
Today on What's My Frame I'm joined by Emmy & Artios nominated, NY-based casting director Sabrina Hyman. Sabrina's credits include the HBO limited series The Night Of, Mrs. Fletcher; the Apple TV + series Invasion; and the independent features Blumenthal and The Illegal. In addition to film and television casting, Sabrina has cast VR shorts (Lincoln in the Bardo), immersive theater (Money Heist: The Experience), and podcasts (This American Life). Prior to casting independently, she worked with, among others, Avy Kaufman, Bialy/Thomas, and Denise Chamian. Past projects include: Steven Spielberg's Lincoln and Robert Redford's The Conspirator; episodics such as Royal Pains (USA) and The Unit (CBS); and pilots for Younger (TV Land) and Lie to Me (FOX). -- Hosted by Laura Linda Bradley Join the WMF creative community now! Instagram: @whatsmyframe TikTok: @whatsmyframe IMDb What's My Frame? official site Join our monthly newsletter! What's My Frame? merch; Coming soon!! --- Support this podcast: https://podcasters.spotify.com/pod/show/whats-my-frame/support
Steven Tylor O'Connor is an Emmy and Artios Award winning Casting Director at Aufiero/Horn Casting, winning an Emmy in 2021 for “The Healing Powers of Dude” (Netflix), being honored as Casting Associate of the year in 2019 by the Casting Society, and winning an Artios for “Andi Mack” (Disney). Steven has been recognized two additional times with Artios nominations. Steven is currently a Casting Director / Associate Casting Director at Aufiero/Horn casting, where other notable projects include: Local Casting Director for Netflix's banner series “13 Reasons Why”, Disney's “Andi Mack”, Netflix's “The OA: Part II”, Facebook's “Five Points”, and SpectreVision's (Elijah Wood) “Seven Stages to Achieve Eternal Bliss” and “Color Out of Space.” Steven was recently elected to the Board of Directors for the Casting Society and serves in Executive Leadership as their Treasurer / VP of Finance. He also sits on the Equity in Entertainment Committee and has championed inclusive casting for underrepresented communities. As a producer, Steven has worked on the Emmy nominated and Indie Series Award winning series "Indoor Boys." ▬▬▬▬▬▬▬▬ STEVEN TYLOR O'CONNOR ⌲ IMDb: https://www.imdb.com/name/nm4209685/ ⌲ IG: https://www.instagram.com/ashleyvrobinson/?hl=en ▬▬▬▬▬▬▬▬ The Moving Spotlight Podcast ⌲ iTunes: https://podcasts.apple.com/us/podcast/the-moving-spotlight/id1597207264 ⌲ Spotify: https://open.spotify.com/show/7cjqYAWSFXz2hgCHiAjy27 ⌲ Patreon: https://www.patreon.com/themovingspotlight ⌲ ALL: https://linktr.ee/themovingspotlight ▬▬▬▬▬▬▬▬ #13ReasonsWhy #AndiMack #TheHealingPowersOfDude #Emmy #Artios #Netflix #Disney #CastingSociety #AufieroHornCasting #Emmys #TVTime #iTunes #Actor #ActorsLife #Believe #Success #Inspiration #Netflix #Hulu #Amazon #HBO #AppleTV #Showtime #Acting #Artist #Theatre #Film #YourBestBadActing #Content #CorbinCoyle #JohnRuby #RealFIREacting #TMS_Pod --- Support this podcast: https://anchor.fm/the-moving-spotlight/support
Artios has raised eyebrows, and cash, raising $320 million since its founding in 2016. Led by CEO, Niall Martin, who spearheaded the development of the PARP inhibitor, Lynparza™, along with the scientific guidance of DDR pioneer, Dr. Graeme Smith, Artios has been able to make a scientific impact. However, in this episode, we will explore their financial impact, as CFO Abid Ansari details how Artios has been able survive and thrive in this challenging market environment.
Welcome to the Badass Babes of Entertainment! On our sixteenth episode of season 2, we interview Steven Tylor O'Connor is an Emmy and Artios Award-winning Casting Director at Aufiero/Horn Casting, winning an Emmy in 2021 for “The Healing Powers of Dude” (Netflix) and being honored as Casting Associate of the year in 2019 by the Casting Society of America, and winning an Artios for “Andi Mack” (Disney). Steven has been recognized two additional times with Artios nominations.A member of the Casting Society of America, he sits on the Equity in Entertainment Committee for the National Board and has championed inclusive casting for underrepresented communities. Steven began his career in New York City working for CBS/Paramount and then NBCUniversal. Now based in Los Angeles, Steven has worked with numerous award-winning and leading casting offices, including Greenstein/Daniels Casting (TVLand's “Hot In Cleveland”), Suzanne Goddard-Smythe Casting (Disney's “Shake It Up”, “Crash and Bernstein”, “Liv & Maddie”, and “KC Undercover”, BET's “The Game” and “Heathers: The Musical” (both the world premiere at the Hudson and Off-Broadway productions).Steven is currently a Casting Director / Casting Associate at Aufiero/Horn casting, where other notable projects include: Local Casting Director for Netflix's banner series “13 Reasons Why”, Disney's “Andi Mack”, Netflix's “The OA: Part II”, Facebook's “Five Points”, and SpectreVision's (Elijah Wood) “Seven Stages to Achieve Eternal Bliss” and “Color Out of Space.” Steven received an Artios nomination for his work on Nickelodeon's Emmy award-winning comedy series “Nicky, Ricky, Dicky & Dawn” and two nominations (one win) for Disney's “Andi Mack.”As a producer, Steven has worked on the Emmy nominated and Indie Series Award-winning series "Indoor Boys." He's also won several awards for his short films.ABOUT THE PODCAST: Brenda Fisher and Meghan Ketz of Badass Babes of Entertainment bring you all the guest interviews, casting tips, and industry news in one captivating podcast. Brought to you this week by Roasted Luxury and Rogue Matter - Download the app ►Join the Movement.Sponsored by: https://roastedluxury.com/ Promo Code BABES15 for a discount on your entire order!▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Listen to the podcast in audio form on every major podcasting app.▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Spotify ► https://open.spotify.com/show/2VRABRKopxehGDfiymXFwOApple ► https://podcasts.apple.com/us/podcast/badass-babes-of-entertainment/id1547723790Google Podcasts ► https://tinyurl.com/4s3v9zksiHeart ► https://iheart.com/podcast/98566932⇩ Follow the Rogue Matter network ⇩Website ► https://www.roguematter.com/Twitter ► https://twitter.com/rogue_matterFacebook ► https://www.facebook.com/weareroguematterSoundcloud ► https://soundcloud.com/roguematterYouTube ► https://youtube.com/roguematter Twitch ► https://twitch.tv/weareroguematter
An inch wide and a mile deep—that's the sort of expertise CSO of Artios Pharma, Dr. Graeme Smith, brings his benchtop. Since his time at Cambridge, Smith has been laser focused on DDR mechanisms, first elucidating, and then translating those observations to create the PARP inhibitor drug, Lynparza. Developed at Kudos Pharma, and later, AstraZeneca, hear Smith recall his “aha” moment for this first-in-class blockbuster drug, as well as his descriptions of his two new DDR-targeting, clinical stage assets developed at Artios that leverage his knowledge of novel DDR pathways—including those that will overcome resistance to PARP inhibition.
The Hollywood Bound Actor Podcast with Christine Horn: Mindset | Acting | Marketing | Auditioning
As we gear up for the Booking Magnet LIVE 2022 Annual Actors Conference, I'm pleased to introduce you to Erica Bream. Enjoy this interview and be sure to connect with us on social media to share your takeaways. Xo! - Christine Connect with Erica Bream here: Instagram- ericasbreamcast Website- http://ericasbreamcasting.com About Erica… ERICA S. BREAM, CSA started working in Casting when she was 18 years old. Since then, she has worked on projects across all mediums, including on titles such as ORDINARY JOE (NBC), TELL ME YOUR SECRETS (Amazon), ALTERED CARBON (Netflix), CRIMINAL MINDS (CBS), STAR TREK: INTO DARKNESS (Paramount), 11:22.63 (Hulu) and many others. Notably, Bream has cast eleven seasons of the prestigious Young Playwrights Festival for The Blank Theatre Company. Over the years, Bream's work in theatre, short film and television casting has garnered her nine Artios nominations and a win in the Los Angeles Theatre category. Join us at the BOOKING MAGNET LIVE 2022 - Actors Conference Learn more: https://bookingmagnetlive.com/ CONNECT WITH ME ON SOCIAL: Instagram: https://www.instagram.com/actresschristinehorn/ Facebook: https://www.facebook.com/actresschristinehorn HBA Website: http://hollywoodboundactors.com/ My Official Website: http://christinehorn.com/ JOIN OUR HOLLYWOOD BOUND ACTORS ONLINE COMMUNITY: https://www.facebook.com/groups/hollywoodboundactors/ JOIN OUR HOLLYWOOD BOUND ACTORS TEXT COMMUNITY: Text the word HBA to (470) 666-7011. Standard messaging and data rates apply. --- Send in a voice message: https://anchor.fm/the-hollywood-bound-actor/message Support this podcast: https://anchor.fm/the-hollywood-bound-actor/support
In this week's episode, Jennifer talks to Erica Hart about all things casting. Erica shares insider tips around the dos, don'ts, & myths of self-tapes, auditions, and social media. They talk about the importance of listening and doing your research, celebrating your firsts & small victories, as well as the importance of collaboration, genuine human connection, and shooting your shot. About Erica: ERICA A. HART, CSA (Casting Director/ Producer) was born and raised in Washington, DC (the actual 202...not 301 or 703.) She graduated from NYU's Tisch School of the Arts, where she studied film and television. She has been casting for over a decade and has loved every minute of it. She started off in network and studio casting moving her way up to Casting Coordinator in the New York Office of ABC Primetime Casting. Erica has appeared in The Hollywood Reporter as a featured rising artist and has cast films that have screened at the Tribeca Film Festival, SXSW, Outfest, Cinequest, and the Cannes Film Festival. THE SURROGATE (a film she cast as well as associate produced) was in INDIEWIRE's Best Movies Eligible for a 2021 Oscar, was a VARIETY CRITICS PICK, and earned Erica her first Artios nomination and win in 2021. She has cast commercials for high-end brands such as Maybelline, Gillette, Hasbro, and Delta, to name a few, and cast H.E.R's music video for FIGHT FOR YOU which won the Academy Award for Best Original Song. Currently, she is the Casting Director for Season 2 of THAT DAMN MICHAEL CHE (HBO MAX) and JODIE produced by Tracee Ellis Ross and Grace Edwards. She cast the pilot BLACK DON'T CRACK (ABC) and season 1 of BUST DOWN (PEACOCK) coming out soon. In 2021 she made her Broadway debut casting two Broadway plays: CHICKEN AND BISCUITS and PASS OVER. She has cast theatrical productions for THE NATIONAL BLACK THEATRE and THE DRAMA LEAGUE. Erica has been the Casting Associate for shows like RAY DONOVAN (SHOWTIME), THE BOLD TYPE (FREEFORM), DEFENDING JACOB (APPLE+), and GODFATHER OF HARLEM (EPIX). She is on the Board of Governors for The Casting Society of America (CSA) and a member of the Television Academy. She also teaches TV auditioning techniques at colleges and universities around the country including Harvard University and NYU's Grad Acting Program. Outside of casting, she has received grants and awards from the Puffin Foundation, New York Television Festival and The Digital Bolex, and has developed series for BET and WeTV. Erica IG: @elove67 Want to coach with Jennifer? Schedule a session here! https://appt.link/jenniferapple Monologue Sourcing Promo Link! https://empoweredartistcollective.com/podcastpromo Learn more: https://www.empoweredartistcollective.com/podcast EAC IG: @EmpoweredArtistCollective EAC TikTok: @EmpowerArtistCollective EAC Facebook: https://www.facebook.com/empoweredartistcollective/ Check Out Our Merch! https://www.empoweredartistcollective.threadless.com/ Any thoughts you'd like to share? Email us at EmpoweredArtistCollective@gmail.com
About Judy: Judy Henderson has been honored by The Ross Reports as one of the top 20 US Film Casting Directors. Highlights include Emmy Award for Outstanding Casting in a Drama Series. 2 Emmy nominations for Outstanding Casting in a Drama Series. 4 Artios Awards for Outstanding Achievement TV Series and Theatre Drama Casting. Artios nomination for Independent Film Feature Casting, and 8 Artios nominations for Off-Broadway Theatre Drama Casting. She has cast innumerable national on-camera and voice-over television commercials. She is a member of the Casting Society of America and Local 817 of the Teamsters Theatrical Union. Select Film credits include Before Midnight, Paranormal 2, 12 and Holding, L.I.E. (6 Independent Spirit Award Nominations, Winner of Best Debut Performance Award), and Before Sunrise. Select TV credits include Homeland-(Emmy Award and 2 Artios Awards - Showtime Series), Love And Betrayal: The Mia Farrow Story (Fox), and Land of Little Rain (PBS). Broadway credits include Barefoot In The Park, and Anna Karenina (4 Tony Nominations). Off-Broadway credits Invasion (Obie Award), Lie of The Mind (Artios Award), The Kid (5 Drama Desk Nominations), and Hurlyburly (Artios Award). Who Hires You for Projects? How does Judy decide who to call in for an audition? What are the qualities of actors you love to bring in? Thinks of it in terms of what she has to do. Goes to the theater a lot What talent means to her Someone who makes me believe they are the person they are playing Someone who will not melt in a situation that may or may not be consistent Trained
DEBORAH AQUILA is one of the most renowned casting directors in Hollywood. She began in NYC with Steven Soderbergh's "Sex, Lies and Videotape" and Uli Edel's "The Last Exit to Brooklyn" before moving to L.A to cast "The Shawshank Redemption." After several years as the head of casting for Paramount, Aquila returned to the independent casting world with Sam Raimi's "The Gift," starring Cate Blanchett, Keanu Reeves, and Katie Holmes, and "What Women Want," directed by Nancy Meyers and starring Mel gibson and Helen Hunt. Her credits also include "La La Land," "The Expendables," "Dexter," "The Shield," "Now You See Me 2," "Live Free or Die Hard," "Crank," and "The Underworld" series. Aquila has been recognized 15 times by the Casting Society of America, winning three Artios awards.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
DEBORAH AQUILA is one of the most renowned casting directors in Hollywood. She began in NYC with Steven Soderbergh's "Sex, Lies and Videotape" and Uli Edel's "The Last Exit to Brooklyn" before moving to L.A to cast "The Shawshank Redemption." After several years as the head of casting for Paramount, Aquila returned to the independent casting world with Sam Raimi's "The Gift," starring Cate Blanchett, Keanu Reeves, and Katie Holmes, and "What Women Want," directed by Nancy Meyers and starring Mel gibson and Helen Hunt. Her credits also include "La La Land," "The Expendables," "Dexter," "The Shield," "Now You See Me 2," "Live Free or Die Hard," "Crank," and "The Underworld" series. Aquila has been recognized 15 times by the Casting Society of America, winning three Artios awards.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The Lord laid on heart several days ago, to start a program called A Word from the Proverbs. A Word from the Proverbs will be a 10 minutes daily show to learn life as much as we can from the book of Proverbs in the Bible. So, in Proverbs 1:1, the Bible says (N. I. V.) The proverbs of Solomon son of David, king of Israel: for gaining wisdom and instruction; for understanding words of insight; for receiving instruction in prudent behaviour, doing what is right and just and fair; for giving prudence to those who are simple, knowledge and discretion to the young— let the wise listen and add to their learning, and let the discerning get guidance— for understanding proverbs and parables, the sayings and riddles of the wise. In this scripture, we see the purpose and the reason why the book of Proverbs was written. Let's read this portion of scripture from the Message Bible: These are the wise sayings of Solomon, David's son, Israel's king— Written down so we'll know how to live well and right, to understand what life means and where it's going; Prov 1: 1-2 So, I've realized that generally, people take longer to learn the things that are already written in the Bible. I myself have taken too long to understand things that we're so close to me. I've decided to take time to explain the great life lessons that are written in the book of Proverbs on a daily basis. And may the Lord God bless this time, may His Presence and His Insights be with us. May He open my mind to reveal things that are secrets and the instructions that you need in your life to move forward. A manual for living, for learning what's right and just and fair; To teach the inexperienced the ropes and give our young people a grasp on reality. God himself does not expect us to know everything either does he reveal all things at once. Jesus said to his disciples, “there are things that I want to tell you, but you're not yet ready for it, the Holy Spirit will be telling you those things”. So, there is a need for us to be learning life and that is the purpose of this show and I will be sharing lessons and revelations that the Lord is giving me from the Book of Proverbs. And this is to learn life and to have a rich experience in this world. Sometimes we go through things and make terrible mistakes simply because we didn't learn life from the Bible. I want to thank you for being so supportive. And I want you to go ahead and like our page, the Artios, or subscribe to our channel on Youtube. And I want you to follow this and learn. Share this Word with many other people to the Glory of God, that his purpose and his mission for this show and for this program will be fulfilled. God bless you. Thank you for reading. Thank you for sharing, subscribing and following this page. God bless you. Pastor Trust. Bye-bye.
Our guest on the podcast today is casting director WENDY O'BRIEN. She's won a Peabody, three Artios awards and was nominated for an Emmy! She's casted Sons of Anarchy, Mayans MC, You're The Worst, It's Always Sunny in Philadelphia, Prison Break, The Runaways, A.P. Bio (with firecracker Mary Sohn), Stumptown (with firecracker Camryn Manheim), Dave, American Vandal, Mr Mayor… and MORE! She also casted Bad Trip (the new Eric Andre movie on Netflix) and 2020's The Way Back with Ben Affleck. Wendy's also a mother, a rower, a quarantine gardener and an absolute DELIGHT! Listen now!
Today on What's My Frame? I'm joined by Artios winning Casting Director Nick Peciaro. Today Nick shares his journey and experience casting theater, television and film. With credits including Showtime's CITY ON A HILL, numerous, Off-Broadway world premieres, INDIGO VALLEY, MAPPLETHORPE, and Season 7 of the multi-Emmy Award-winning Showtime series HOMELAND. Nick is a wealth of information and insight! Today he shares his road to casting, his long running love affair with the arts and what inspires his work. An East Coast native born and raised in New England, Nick attended Emerson College in Boston where he graduated cum laude with a Bachelor of Arts in Theatre Studies; before moving to New York to start the next chapter of his career. --- Support this podcast: https://anchor.fm/whats-my-frame/support
Casting directors are often seen as gatekeepers to opportunities in the industry - but does the multi-hyphenate approach help them? The answer is yes. We've all had audition horror stories - and whether or not it's the casting directors fault our own, it's never too late to live and learn. And as always, knowing yourself as a multi-hyphenate often is the answer to avoid those icky situations. Join one of New York's leading casting directors Stephanie Klapper as she breaks down and opens up about the casting director process. Though casting directors seem like distant people sitting behind tables, we have to remember they are human beings in search of connection, just as the actor is. So - when should an artist show up for their call of duty? What type of resume should you send? Do you want to see the chemical makeup of the multi-hyphenate artist or do you want to see that I once was in the ensemble of Cabaret? How can an actor make an experience better for the casting director? What purpose does the headshot serve in 2021? All these questions, and many more, are answered in this amazing episode. The multi-hyphenate is extremely useful to the casting director, because as Stephanie states, “Sometimes we don't even know what we're looking for!” The rules of auditioning changes daily - especially after experiencing a shut down like the industry has, which obviously will affect the future audition protocol. “It's a great time to get to know people,” Stephanie says, “in a way that when we're all running too quickly - we don't get to.” Actors aren't the only ones pivoting in the pandemic - you guessed it, casting directors are as well. As well as getting inspiring tips on how to apply agency to your auditions, get a behind the table look as to what a casting director is experiencing during this time away from normalcy. This episode also features a questions from a listener in the segment YOU GOT A QUESTION? where Michael answers a question sent to him through social media. This week's question, sent in from Erika E. and focsuses on collaboration. How do we find collaborators? Stephanie Klapper is a New York based Casting Director who has been in the business for 25 plus years. Her work is frequently seen on Broadway, Off-Broadway, regionally, internationally, on television, and film. Projects she has cast have won numerous awards including the Tony, OBIES, Drama Desk, Pulitzer Prize, Sundance Audience Award, Cannes Prize Du Publique, Comic Con and Artios. Stephanie, along with her incredible casting team, comprise Stephanie Klapper Casting, an Independent Casting Group who is known for their limitless imagination and creativity and for their work on a wide range of projects all over the country and the world. Frequent and longtime collaborators include Primary Stages, Mint Theater Company, NY Classical Theatre, american vicarious, The Peccadillo, Voyage Theatre, Masterworks, Resonance Ensemble, Hudson Valley Shakespeare Company, Capital Repertory Theatre, Cincinnati Playhouse, Actors Theatre of Louisville, Adirondack Theatre Festival, Ford's Theatre, Kansas City Rep, The New Theatre, The Philadelphia Orchestra, as well as many more in New York, the regions, and internationally. Ms. Klapper is passionate about working with creative teams to develop new work and expand the scope of established work. In addition to casting and teaching, Ms. Klapper is a member of the New York Board of the Casting Society of America, Casting Society Cares, and New York Women in Film. She is passionate about continuing to expand and champion diversity, equity, equality and inclusion in the business. She loves working with emerging artists to help them develop their careers. Connect with Michael: @themichaelkushner (IG and TikTok) @dearmultihyphenate (IG) www.michaelkushneronline.com Produced by Alan Seales and the Broadway Podcast Network. Learn more about your ad choices. Visit megaphone.fm/adchoices
Pro Wrestling Fans Check out our exclusive interview with August Artois as he takes us through his Journey on how it all began on his Pro Wrestling Career, working with WWN Live, ACW, making appearances on WWE RAW, RETRIBUTION, NXT, calling out Garrett Bischoff and more!!! what an amazing time we had with August, has a bright future coming for him. please subscribe to our channel, enjoy the show!!! #COD#AUGUSTARTIOS#WWNLIVE#ACW#WWE#NWA#NXT #WRESTLINGPODCAST#AEW#PROWRESTLINGPODCAST#WRESTLING #PROWRESTLING# make sure you subscribe to our youtube channel https://www.youtube.com/channel/UCo7TZmSuE-PX_6fBVkDbNZA --- Send in a voice message: https://anchor.fm/circle-of-debate-podcast/message
Today on What's My Frame? I'm joined by casting director and Artios winner, Lori Wyman. Lori has been casting films, television, and commercials in South Florida since '79. Brining to life projects like MIAMI VICE, 21 JUMPSTREET, & WISEGUY. Today we not only get loads of advice from a veteran Southeast casting director but also some fun behind the scenes casting stories. Outside of casting Lori received her Master's Degree from NSU with a concentration in Drama Therapy. She pursued the degree in order to help actors with Audition Anxiety. Today we talk more about Lori's acting classes & workshops at The Organic Actor. In '90 Lori opened her own office in North Miami Beach. Recent credits include THE RIGHT STUFF, THE ASSASSINATION OF GIANNI VERSACE: AMERICAN CRIME STORY, FAST 8, BALLERS and BLOODLINE. Please join me in welcoming Lori Wyman to the show theorganicactor.com --- Support this podcast: https://anchor.fm/whats-my-frame/support
Today on What's My Frame? I'm joined by casting director Thomas Sullivan. Thomas started his career as an actor, and today shares the story of how he transitioned into casting. In his career he's worked in television, commercials and film. He recently won an Artios award for his work on the Oscar winning film Green Book. 2020 has presented it's fair share of challenges to both actors and casting directors alike; Thomas shares some personal insight into navigating the digital casting room. As well as how to self advocate when you're auditing without representation, a challenge many actors face. Please join me in welcoming Thomas Sullivan to the show! --- Support this podcast: https://anchor.fm/whats-my-frame/support
Stephanie Klapper is a New York based Casting Director who has been in the business for 25 plus years. Her work is frequently seen on Broadway, Off-Broadway, regionally, internationally, on television, and film. Projects she has cast have won numerous awards including the Tony, OBIES, Drama Desk, Pulitzer Prize, Sundance Audience Award, Cannes Prize Du Publique, Comic Con and Artios. Stephanie, along with her incredible casting team, comprise Stephanie Klapper Casting, an Independent Casting Group who is known for their limitless imagination and creativity and for their work on a wide range of projects all over the country and the world.Frequent and longtime collaborators include Primary Stages, Mint Theater Company, NY Classical Theatre, american vicarious, The Peccadillo, Voyage Theatre, Masterworks, Resonance Ensemble, Hudson Valley Shakespeare Company, Capital Repertory Theatre, Cincinnati Playhouse, Actors Theatre of Louisville, Adirondack Theatre Festival, Ford’s Theatre, Kansas City Rep, The New Theatre, The Philadelphia Orchestra, as well as many more in New York, the regions, and internationally. Recent projects include: The Night of the Iguana (La Femme Theatre Productions); Chekhov/Tolstoy Love Stories (Mint); Sideways, the Experience (Peccadillo); A Sign of the Times (Off-Broadway); The 24-Hour Plays on Broadway Gala Celebrating Kathy Bates; Paradise Lost (FPA/Directors Company); Miss America’s Ugly Daughter (Off-Broadway); Grace, a song cycle (Actor’s Theatre of Louisville); Once on this Island (Cincinnati Playhouse/Actor’s Theatre); The Hope Hypothesis (Voyage Theatre Co.); The Importance of Being Earnest (NY Classical); Hamlet (Utah Shakespeare Festival); Daniel’s Husband (Penguin Rep/Primary Stages); Actually We’re F**ked (Cherry Lane Theatre); A Letter to Harvey Milk (Off-Broadway); Pride and Prejudice (Kate Hamill)(Hudson Valley Shakespeare Festival/Primary Stages); Candide, Westside Story and Bernstein’s Mass (Philadelphia Orchestra). Select Recent Broadway includes: Bronx Bombers; A Christmas Story, the Musical; Dividing the Estate; It Ain’t Nothin’ But the Blues.Select Film/TV credits: Netuser (with Denis O’Hare); Epiphany V; Theresa Rebeck’s Poor Behavior; Stag; Alice Jacobs is Dead (Adrienne Barbeau); The Feast of the Goat (Isabella Rossellini); Uncertain Terms; Altamont Now!; Sidewalk Stories; Roberta; Eve Ensler’s One Billion Rising, the video; webisode: Battery Park; Parking Lot Chronicles; Highlights of a Mom’s Life. Television: Lazytown.Ms. Klapper is a graduate of Manhattan’s famed Music and Art High School and SUNY College at Purchase. She is a frequent guest teacher and lecturer at many colleges and universities including: New York University (The New Studio on Broadway), Drew, UNCSA, USC, Oklahoma University, Ohio University, Kenyon College, University of Michigan, UMKC, Florida State University (Asolo), Skidmore College, Penn State, SUNY Purchase, SUNY New Paltz, Indiana University, UNC Chapel Hill, New York Conservatory of the Dramatic Arts, and the Tepper Semester through Syracuse University, where she is also a mentor to students interested in pursuing work in the casting profession. Ms. Klapper is passionate about working with creative teams to develop new work and expand the scope of established work. In addition to casting and teaching, Ms. Klapper is a member of the New York Board of the Casting Society of America, Casting Society Cares, and New York Women in Film. She is passionate about continuing to expand and champion diversity, equity, equality and inclusion in the business. She loves working with emerging artists to help them develop their careers.
Today on Whats My Frame? I'm joined by casting director, Sunday Boling. Today Sunday shares some invaluable lessons from her time in casting; including her perspective on making bold choices in the room and the future of virtual casting. Her career started at 20th Century Fox, working on films like Ice Age, Dude, Where’s My Car?, and Big Momma’s House. Her time at FOX not only allowed Sunday to work on a wide variety of projects to learn what she loved, but also introduced her to now business partner Meg Morman. The ladies opened Morman Boling Casting in 2004. Once given the freedom to pick projects that speak to them, the ladies quickly made a name for themselves! Though you might be surprised what "actor staple" the ladies used to get the word out for their new office. Now with numerous Artios nominations and wins to their credit they need no introduction; helping bring to life projects like Hello, My Name Is Doris starring Sally Fields and Waitress starring Keri Russell, the film that set into motion Broadway's beloved hit! Regardless of how busy she gets, Sunday makes the time to give back to her creative community currently serving on the national board of CSA. She and Meg also serve as Casting Consultants for the Film Independent's Directing Lab. Please join me in welcoming Sunday Boiling to the show! -- Want to learn more about Sunday? Visit mormanbolingcasting.com --- Support this podcast: https://anchor.fm/whats-my-frame/support
Stephanie Klapper (Stephanie Klapper Casting) is a New York-based Casting Director whose work is frequently seen on Broadway, Off-Broadway, regionally, internationally, on television, and on film. Projects she has cast have won numerous awards, including the Tonys, OBIES, Artios, Drama Desk, Pulitzer Prize, Sundance Audience Award, Cannes Prize Du Publique, and Comic Con awards. Frequent and long time collaborators include Primary Stages, Mint Theater Company, New York Classical Theatre, american vicarious, The Peccadillo, Masterworks, Resonance Ensemble, Hudson Valley Shakespeare Company, Cincinnati Playhouse, Capital Repertory Theatre, Actors Theatre of Louisville, Adirondack Theatre Festival, Ford's Theatre, Kansas City Rep, The New Theatre, as well as many more both in New York and regional theatres around the country.
Michael is the recipient of 9 Artios awards, presented by the Casting Society of America for Outstanding Achievement in Casting. Michael has cast over 1000 theatre productions, including shows produced at the Ahmanson Theatre, the Hollywood Bowl, Pasadena Playhouse, Mark Taper Forum, Kirk Douglas Theatre, Walt Disney Concert Hall, Geffen Playhouse, International City Theatre, La Jolla Playhouse, Getty Villa, Ricardo Montalban Theatre, Garry Marshall Theatre, Colony Theatre, Theatre @ Boston Court, 24th St. Theatre, The Soraya, San Francisco Symphony, Arizona Theatre Company, both the Palazzo Theatre and the Paris Theatre in Las Vegas, Arkansas Rep, Kentucky Shakespeare Festival, Indiana Rep, as well as several national tours. Michael’s credits also include numerous films, over 1,000 commercials, and multiple TV series. Michael, who also teaches at UCLA, is President of the Foundation for New American Musicals, and serves on the Board of Directors for Camp Bravo. Contact Michael - https://michaeldonovancasting.com/ https://www.instagram.com/michaeldono... https://twitter.com/MD_Casting CUT THE ACT CUT THE ACT - https://www.instagram.com/cuttheact_p Mikes Instagram - https://www.instagram.com/mikes_insta https://mikefarrell.com.au/ CONTACT Mike at "CUT THE ACT" Mike@mikefarrell.com.au --- Send in a voice message: https://anchor.fm/mike-farrell1/message
Today we speak with a wonderful casting director and such a sincere human being, Stephanie Klapper. Stephanie is based out of NY and has worked on Broadway, Off-Broadway, regionally, internationally, on television, and on film. Projects she has cast have won numerous awards, including the Tonys, OBIES, Artios, Pulitzer Prize, Sundance Audience Award, Cannes Prize Du Publique, and Comic Con awards.
Today my guest on the Hometown to Hollywood podcast is Los Angeles casting director Krisha Bullock, of Bullock and Snow Casting. Listen to the first 10 minutes here for free, or become a Friend of the Podcast for access to the full interview, as well as access to the entire collection of over 100 other inspiring and educational episodes designed to help you succeed in the entertainment industry. It’s easy! In your browser bar, go to https://hometowntohollywood.supportingcast.fm/ and for just $5 a month—about the price of latte– become a member. Your support allows me to continue to do the work that supports you, and the dreams of your child, or even your own dreams. Thank you! Krisha Bullock is a multi-award winning Casting Director and nominee with over 19 year of casting experience, specializing in youth programming. She has been nominated for dozens of Artios awards by the Casting Society of America, and is a several time winner of the Seymour Heller Award for Television Casting Director of the Year. She is ridiculously proud of her mentorship of thousands of hopeful young people, helping them break into the industry by navigating them toward a professional career. Krisha is best known for casting All That, Keenan and Kel, Zoey 101, True Jackson VP, iCarly, Victorious, Sam & Cat, DeGrassi: the Next Generation, Game Shakers, and Henry Danger, among other hit shows. She is a member of the Casting Society of America. We talk about how actors can take control of their auditions, how they can best prepare for success when production opens up again after the pandemic, and so much more. Join us! Some of my favorite quotes from our conversation: “The best actors act from the inside out.” “It is such a joy to make that phone call, and virtually make somebody’s dreams come true.” “Multicamera came from theater.” “We are looking for someone to walk in and show us how the ole should be done.” “I am looking for someone to come in and play the scene exactly the way they would play the scene on set.” “The time that you’re in the room is the time to teach us who you are, & who you’re going to be as a professional on stage.” “We want them to be amazing. We want them to book the role.” “Casting isn’t an adversary; we’re actually part of your team.” “I wish actors would watch their tapes back.” “We are ultimately hiring human beings to be on our set.” “We champion you. Not just for this particular role, but for every role.” “Parents should be like the Secret Service on set. They’re there to protect, and disappear.” “Acting is one of the very few things you can do from birth to death.” Follow Krisha Bullock here: Website: https://bullockandsnowcasting.com/ Twitter: @BullockAndSnow Facebook: @BullockAndSnowCasting Krisha Bullock shared a career’s worth of insight in her interview, and still we only scratched the surface of her wisdom. Imagine what you could learn in an hour of one-on-one with an acting career expert? If you could use some help getting started in an acting career, or jump-starting one that has stalled, book a consultation with me. A single session can save you months and years of frustration, time and money. I look forward to talking with you!
Today on WHAT'S MY FRAME? I'm chatting with casting director Amey René! Amey is an Artios nominee as well as the indie darling that's cast some of your favorite festive films at Sundance, SXSW, Tribeca, Cannes and Toronto. She's brought to life BLUE JAY with Sarah Paulson, PADDLETON and CAPTAIN FANTASTIC. On the TV side of Amey's career she's cast the Netflix Original Series EVERYTHING SUCKS!, Season 2 of the Sundance Original Series THIS CLOSE along with a number of other projects. To learn more about Amey you can follow her on Instagram @ameyrenecasting --- To learn more visit: whatsmyframe.com or @whatsmyframe on Instagram Hosted by: Laura Linda Bradley --- Support this podcast: https://anchor.fm/whats-my-frame/support
"If you're good at your job, you should be anticipating all the time: where's this project going to end up in 3 months, 6 months, a year? What are the risks? What do we need to do to overcome them?" In this episode, we welcome Niall Martin, CEO of Artios Pharma, a company harnessing the power of the body's natural DNA repair capability to fight cancer. Niall talked to us about his career, including:
Today on What's My Frame? we're talking with Casting Director Geralyn Flood. Geralyn has worked on projects for ALL the major networks ABC, NBC, CBS, The CW, The WB, Freeform, Disney, Nickelodeon, Snapchat... and the list just continues to grow! Geralyn's first casting job was working with Jeff Greenberg on FRASIER, yes that FRASIER. While at Jeff's office she also worked on ACCORDING TO JIM, and I'M WITH HER. She then spent four years at Zane/Pillsbury working on GOOD LUCK CHARLIE, WHITE COLLAR, and GARY UNMARRIED, and countless unseen pilots; as working actors I think we all can relate! In addition to her impressive TV credits, Geralyn has worked on indie and studio films including three Mark Waters features JUST LIKE HEAVEN, THE SPIDERWICK CHRONICLES, and GHOSTS OF GIRLFRIENDS PAST. Geralyn is currently working with Marc Hirschfeld on a number of projects including the CBS favorite, MAN WITH A PLAN starring Matt LeBlanc. In 2019 Geralyn reteamed with Norman Lear for his LIVE IN FRONT OF A STUDIO AUDIENCE: ALL IN THE FAMILY AND THE JEFFERSONS SPECIAL, for which she won her second Artios award for excellence in casting! Please join me in welcoming the the exceptional Geralyn Flood! --- To learn more visit: whatsmyframe.com or @whatsmyframe on Instagram Hosted by: Laura Linda Bradley --- Support this podcast: https://anchor.fm/whats-my-frame/support
Jen Rudin is an award-winning Casting Director, writer and audition coach, and author of the book Confessions of a Casting Director. She has won two Artios awards for casting, and recently nominated for a 2019 Casting Society of America Artios award for her short film Lucy in the Sky. She owns and operates Jen Rudin Casting which casts for film, television, commercials, animation and theater in New York and Los Angeles. Jen also writes a monthly column for Backstage.com on Voice Over casting. Jen Rudin grew up in New York City and began her professional acting career at age eight. She created many new roles in new plays, starred in several television movies, and did commercials. At age twelve, she had her first epiphany at a final callback that she wanted to be a Casting Director – a perfect blend of her photographic memory and love of actors. Her casting philosophy combines the challenge of solving the casting puzzle – who is best for the role? – while creating an honest, positive and comfortable audition environment, in what is often the most stressful of situations. www.jenrudincasting.com Follow @rudinj --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/confessionsofanactress/message Support this podcast: https://anchor.fm/confessionsofanactress/support
I don't know how these two have time to sleep. This is just a partial list of the projects they cast:BLACKISHMIXEDISHGROWNISHKOBRA KAIJUICY STORIESSCROLL WHEEL OF TIMEand they are Artios nominees for FULLER HOUSE!They also happen to be awesome humans. I am so proud to know them and I am positive you will love this episode!
Boy, oh boy! I love this episode!Co-Hosted by my dear friend, actor Elizabeth Frances, we head out to the GEFFEN PLAYHOUSE, which is one of THE most prestigious theaters in Los Angeles. We sat down with our new favorite human, resident Casting Director Phyllis Shuringa, to discuss her Artios nomination, the differences between stage and TV acting, and even the differing unions and rules. I learned so much and I did not want to leave! ...but she made me.
Becky Silverman and Lisa Zambetti are the CDs behind the Artios nominated short film AKEDA. You have to listen to the story behind the casting. It's a great one!They are both kind people and fun to audition with. Whether it is for an indie feature a hit network TV series like CRIMINAL MINDS, they treat actors with patience, kindness and dignity. Lisa is also the co-host and co-creator of the hit podcast REAL CRIME PROFILE!
Dear Listeners, It was so great to hang out with Robert, Eric and Carol. The principals of UDK Casting. Not only are they people that I trust and admire, I'm envious to have friends who are doing what they love, and have been able to do it for decades. It's the perfect partnership because they share values, compliment each other, yet retain their uniqueness. They have earned the HOYT BOWERS AWARD, which is one of the most prestigious awards in the Casting community. It will be given to them at the Artios ceremony in LA in late January 2019.I am so happy for them and loved spending a half an hour recording them for this podcast so you can get to know them better as well. Congrats guys (and gal)Seth Coltanwww.obSETHed.com
It was such an honor to sit down recently with Casting Director Gary Zuckerbrod to discuss his 2019 Artios Nomination for the Netflix film THE KISSING BOOTH.We also discussed his career path and some of the way casting has changed since he first got into the business.I'm going to convince him one day to start a voice-over career if he ever has spare time. Just listen to this episode and you will understand why I think he could be hugely successful doing that!-Sethwww.obSETHed.com
Meg Morman and Sunday (Sunny) Boling are the casting team that make up Morman Boling Casting in Los Angeles California. They are nominated for a 2019 Artios Award for the Short Form series RELATIONSHIP STATUS. They were so much fun to hang out with while recording this episode. I learned a lot from them, and I think you will too.https://www.mormanbolingcasting.com/relationship-status
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Actor ALEX MACNICOLL on the red carpet at the 31st Annual Artios Awards 2016. He was attending to support casting director EDIE BELASO nominated in the Television Pilot Comedy category for Amazon's television series "TRANSPARENT" casting achievements.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Casting Director APRIL WEBSTER on the red carpet at the 31st Annual Artios Awards 2016. Casting Society of America nominated her in the Feature Film Big Budget Drama category for motion picture "STAR WARS: THE FORCE AWAKENS" casting achievements.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Casting Directors ALEXIS FRANK KOCZARA, CHRISTINE SMITH SHEVCHENKO and AMANDA LENKER DOYLE on the red carpet at the 31st Annual Artios Awards 2016. Casting Society of America nominated them in the Television Pilot Comedy category for television series "BLACK-ISH" casting achievements.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Casting Director LEAH DANIELS-BUTLER on the red carpet at the 31st Annual Artios Awards 2016. Casting Society of America nominated her in the Television Pilot Drama category for the television series "Empire" casting achievements.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Emmy®️-nominated Casting Director BERNARD TELSEY on the red carpet at the 31st Annual Artios Awards 2016. Casting Society of America honored him with the Hoyt Bowers Award for his Broadway and Off-Broadway casting career achievements.
DEBORAH AQUILA is one of the most renowned casting directors in Hollywood. She began in NYC with Steven Soderbergh's "Sex, Lies and Videotape" and Uli Edel's "The Last Exit to Brooklyn" before moving to L.A to cast "The Shawshank Redemption." After several years as the head of casting for Paramount, Aquila returned to the independent casting world with Sam Raimi's "The Gift," starring Cate Blanchett, Keanu Reeves, and Katie Holmes, and "What Women Want," directed by Nancy Meyers and starring Mel gibson and Helen Hunt. Her credits also include "La La Land," "The Expendables," "Dexter," "The Shield," "Now You See Me 2," "Live Free or Die Hard," "Crank," and "The Underworld" series. Aquila has been recognized 15 times by the Casting Society of America, winning three Artios awards.
Hosts Eva Tingley & Kathy Deitch went on location to Melissa Masse's shop in Los Angeles to talk with Artios award winning casting director Felicia Fasano, and top agent, Dana Sims about body size in Hollywood.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Actress EMILY ROBINSON on the red carpet at the 31st Annual Artios Awards 2016. She was attending to support casting director EYDE BELASCO nominated in the Television Pilot Comedy category for Amazon's television series TRANSPARENT casting achievements.
#ICYMI WINDI WORLD DAILY with WINDI WASHINGTON interviewed Casting Directors MEG MORMAN & SUNDAY BOLING on the red carpet at the 31st Annual Artios Awards 2016. Casting Society of America nominated them in the Web Series category for the web series series "Olive and Mocha, Unscreened Summer Series" casting achievements.
The girls sip on a refreshing Stella Artios and discuss the Waco Siege of 1993 and the mysterious disappearance of the crew of the Sarah Joe.
© 2020-2025 Ivy Podcast Discovery LLC
